The Money Times | Novartis Looks For Magic Pill Forbes - The Swiss drugmaker Novartis has been given the green light by the European Commission to sell Extavia, a multiple sclerosis drug. Novartis MS Drug, Rival to Bayer's, Wins EU Approval (Update3) UPDATE 1-Novartis' MS drug gets approval in EU |
Link - Mon, 26 May 2008 01:47:05 GMT - Feed (1 subs)
Sent using SendMeRss.com.
Visit here to unsubscribe from Google News - Business.
Recommended Feeds/Actions
No comments:
Post a Comment